FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1480250795> ?p ?o ?g. }

• W1480250795 endingPage "300" @default.
• W1480250795 startingPage "294" @default.
• W1480250795 abstract "Due to the lack of direct head-to-head trials, there are limited data regarding the comparative effectiveness of induction-maintenance sequences. The objective of this study was to develop a cost-effectiveness model to compare induction-maintenance sequences in the US for the treatment of advanced non-squamous NSCLC.Decision analytic modelling was used to synthesize the treatment effect and baseline risk estimates for nine induction and maintenance treatment sequences, reflecting treatments used in the US. The model was structured using an area-under-the-curve approach and sensitivity analyses were conducted. Model validation was conducted by an independent third party.All active maintenance therapy-containing regimens, with the exception of gemcitabine+cisplatin (first-line)→erlotinib (maintenance), were more costly than induction-only regimens. Concerning treatments that may be cost effective, the incremental costs per life-year gained were $121,425, $148,994, and $191,270 for gemcitabine+cisplatin→erlotinib versus gemcitabine+cisplatin→best supportive care (BSC), pemetrexed+cisplatin→BSC versus gemcitabine+cisplatin→erlotinib, and for pemetrexed+cisplatin→pemetrexed versus pemetrexed+cisplatin→BSC, respectively. All other regimens were found to be dominated (carboplatin+paclitaxel→BSC; carboplatin+paclitaxel→erlotinib; carboplatin+paclitaxel→pemetrexed; bevacizumab+carboplatin+paclitaxel→bevacizumab) or extendedly dominated (cisplatin+gemcitabine→pemetrexed). Sensitivity analyses demonstrated stability.Depending on the specific cost-effectiveness threshold used by a decision maker, the most cost-effective treatment sequence may include the referent comparator gemcitabine+cisplatin and the studied regimens of gemcitabine+cisplatin→erlotinib, pemetrexed+cisplatin→BSC, or pemetrexed+cisplatin→pemetrexed." @default.
• W1480250795 created "2016-06-24" @default.
• W1480250795 creator A5018460766 @default.
• W1480250795 creator A5029103949 @default.
• W1480250795 creator A5043706727 @default.
• W1480250795 creator A5045328415 @default.
• W1480250795 creator A5061100035 @default.
• W1480250795 creator A5067169119 @default.
• W1480250795 creator A5090793200 @default.
• W1480250795 date "2015-09-01" @default.
• W1480250795 modified "2023-09-25" @default.
• W1480250795 title "Cost-effectiveness of first-line induction and maintenance treatment sequences in non-squamous non-small cell lung cancer (NSCLC) in the U.S." @default.
• W1480250795 cites W1966347188 @default.
• W1480250795 cites W1998034034 @default.
• W1480250795 cites W2005244154 @default.
• W1480250795 cites W2012368323 @default.
• W1480250795 cites W2030747356 @default.
• W1480250795 cites W2037139573 @default.
• W1480250795 cites W2037809152 @default.
• W1480250795 cites W2050628416 @default.
• W1480250795 cites W2058056848 @default.
• W1480250795 cites W2060251426 @default.
• W1480250795 cites W2093157946 @default.
• W1480250795 cites W2096216990 @default.
• W1480250795 cites W2096552494 @default.
• W1480250795 cites W2099725888 @default.
• W1480250795 cites W2100785570 @default.
• W1480250795 cites W2100912832 @default.
• W1480250795 cites W2112621029 @default.
• W1480250795 cites W2143532751 @default.
• W1480250795 cites W2145835533 @default.
• W1480250795 cites W2169961966 @default.
• W1480250795 cites W2170239385 @default.
• W1480250795 doi "https://doi.org/10.1016/j.lungcan.2015.05.020" @default.
• W1480250795 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26122345" @default.
• W1480250795 hasPublicationYear "2015" @default.
• W1480250795 type Work @default.
• W1480250795 sameAs 1480250795 @default.
• W1480250795 citedByCount "16" @default.
• W1480250795 countsByYear W14802507952016 @default.
• W1480250795 countsByYear W14802507952017 @default.
• W1480250795 countsByYear W14802507952018 @default.
• W1480250795 countsByYear W14802507952019 @default.
• W1480250795 countsByYear W14802507952020 @default.
• W1480250795 countsByYear W14802507952021 @default.
• W1480250795 countsByYear W14802507952022 @default.
• W1480250795 crossrefType "journal-article" @default.
• W1480250795 hasAuthorship W1480250795A5018460766 @default.
• W1480250795 hasAuthorship W1480250795A5029103949 @default.
• W1480250795 hasAuthorship W1480250795A5043706727 @default.
• W1480250795 hasAuthorship W1480250795A5045328415 @default.
• W1480250795 hasAuthorship W1480250795A5061100035 @default.
• W1480250795 hasAuthorship W1480250795A5067169119 @default.
• W1480250795 hasAuthorship W1480250795A5090793200 @default.
• W1480250795 hasBestOaLocation W14802507951 @default.
• W1480250795 hasConcept C121608353 @default.
• W1480250795 hasConcept C126322002 @default.
• W1480250795 hasConcept C143998085 @default.
• W1480250795 hasConcept C2776256026 @default.
• W1480250795 hasConcept C2776694085 @default.
• W1480250795 hasConcept C2777240266 @default.
• W1480250795 hasConcept C2777802072 @default.
• W1480250795 hasConcept C2778087573 @default.
• W1480250795 hasConcept C2778239845 @default.
• W1480250795 hasConcept C2779438470 @default.
• W1480250795 hasConcept C2780258809 @default.
• W1480250795 hasConcept C2781451048 @default.
• W1480250795 hasConcept C71924100 @default.
• W1480250795 hasConcept C98274493 @default.
• W1480250795 hasConceptScore W1480250795C121608353 @default.
• W1480250795 hasConceptScore W1480250795C126322002 @default.
• W1480250795 hasConceptScore W1480250795C143998085 @default.
• W1480250795 hasConceptScore W1480250795C2776256026 @default.
• W1480250795 hasConceptScore W1480250795C2776694085 @default.
• W1480250795 hasConceptScore W1480250795C2777240266 @default.
• W1480250795 hasConceptScore W1480250795C2777802072 @default.
• W1480250795 hasConceptScore W1480250795C2778087573 @default.
• W1480250795 hasConceptScore W1480250795C2778239845 @default.
• W1480250795 hasConceptScore W1480250795C2779438470 @default.
• W1480250795 hasConceptScore W1480250795C2780258809 @default.
• W1480250795 hasConceptScore W1480250795C2781451048 @default.
• W1480250795 hasConceptScore W1480250795C71924100 @default.
• W1480250795 hasConceptScore W1480250795C98274493 @default.
• W1480250795 hasIssue "3" @default.
• W1480250795 hasLocation W14802507951 @default.
• W1480250795 hasLocation W14802507952 @default.
• W1480250795 hasOpenAccess W1480250795 @default.
• W1480250795 hasPrimaryLocation W14802507951 @default.
• W1480250795 hasRelatedWork W1480250795 @default.
• W1480250795 hasRelatedWork W2028314225 @default.
• W1480250795 hasRelatedWork W2044560382 @default.
• W1480250795 hasRelatedWork W2338335290 @default.
• W1480250795 hasRelatedWork W2373050420 @default.
• W1480250795 hasRelatedWork W2510120704 @default.
• W1480250795 hasRelatedWork W2599463965 @default.
• W1480250795 hasRelatedWork W2774698410 @default.
• W1480250795 hasRelatedWork W2906748950 @default.
• W1480250795 hasRelatedWork W4244085256 @default.

• next